Related Experiment Video
Updated: Feb 27, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
[[TUBERCULOSIS ANNUAL REPORT 2014 - (3) Case Finding and Condition of Tuberculosis Patients on Diagnosis].]
Abstract:
Tuberculosis (TB) surveillance data from 2014 was reviewed, with respect to modes of detection, symptoms at diagnosis, diagnostic delay, radiographic findings, comor- bidity, and drug susceptibility test (DST) results. Of the 19,615 newly registered TB cases, 82.8% were diagnosed while seeking care for, or during treatment of, other illnesses. Of the 15,149 patients with pulmonary TB (PTB), 55.9% presented with respiratory symptoms, while 18.0% presented with non-respiratory symptoms, and 25.5% were asympto- matic. Considerable delay to the initiation of treatment following the appearance of symptoms was observed among the younger symptomatic smear-positive TB patients. Over 35% of patients aged 35-59 years did not seek care for more than 2 months after the initial appearance of symptoms. The proportion of PTB patients with advanced or far- advanced cavitation peaked at 49.9% among males aged 60- 64 years, while it remained constant at around 25% among females in all age groups. Positive HIV test results were obtained in 0.2% (n- 45) of the newly registered TB patients, among which 86.7% were male and 22.2% were foreign-born. In addition, 16.3% of male and 10.5% of female newly diagnosed patients had diabetes mellitus. Of the 10,259 culture-positive PTB patients, DST results were available for 74.5% of patients. In previously untreated patients, the proportions of multi-drug resistant TB, any isoniazid resistance, and any rifampicin resistance were 0.6 %, 4.1 %, and 0.8%, respectively; among previously treated patients, these proportions were 3.3%, 12.7%, and 3.8%, respectively.
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Physical Assessment of the Respiratory Tract I: Health History
Subjective Data
Subjective data provides vital information about the patient's health history and symptoms. This data is typically collected through interviews in which patients describe their experiences, symptoms, and concerns.
Health history and...

